WCPO: University of Cincinnati Cancer Center survivorship services connect patients to help after treatment
WCPO recently highlighted the University of Cincinnati Cancer Center's Survivorship & Supportive Services Program that connects survivors to the resources they need to thrive.
"It's taught me that I'm truly not alone," breast cancer survivor and program participant Sharen King told WCPO. "I didn't have the time to be afraid, I just knew I had to take care of me. I have nine nieces and nephews, and I'm Auntie."
Elizabeth Shaughnessy, MD, Cancer Center member, adjunct professor, vice chair for patient experience and division director of survivorship in the UC College of Medicine, said there are more than 18 million cancer survivors living in the United States currently, with that number expected to grow to 20 million by 2025.
"It's a lot of people and with that comes a lot of baggage and we need to be able to address those medical problems going forward," Shaughnessy said.
The Survivorship & Supportive Services Program is open to patients at any health system who are in cancer remission and may be facing new challenges. Services include oncology primary care, physical, occupational and music therapy and mental health, fertility, sexual health and sleep resources to help people living with cancer get "back to normal" as much as possible.
Featured photo at top of Breast Cancer Awareness Month ribbon. Photo/Lludmila Chernetska/iStock.
Related Stories
UC biologist talks about 'pearmageddon'
March 16, 2026
WLWT talks to UC biologist and Department Head Theresa Culley about invasive, nonnative Callery pear trees that are spreading across Ohio forests after they were introduced by landscapers more than 50 years ago.
Local media highlight completion of Blood Cancer Healing Center fourth and fifth floors
March 16, 2026
Local media including WLWT and the Cincinnati Business Courier highlighted the opening of research laboratories and the UC Osher Wellness Suite and Learning Kitchen at the University of Cincinnati Cancer Center’s Blood Cancer Healing Center.
Trial results support weekly buprenorphine treatment of opioid use disorder during pregnancy
March 16, 2026
Supported by the National Institutes of Health (NIH), researchers led by the University of Cincinnati's John Winhusen published clinical trial results in JAMA Internal Medicine that found administering weekly injectable extended-release buprenorphine for treatment of opioid use disorder during pregnancy led to higher rates of abstinence from illicit opioids than buprenorphine given daily under the tongue, one of the standard methods of treatment.